1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Farallon Capital Management Llc Buys The Medicines Co, Salesforce.com Inc, Thermo Fisher Scientific Inc, Sells Celgene Corp, Altaba Inc, Citrix Systems Inc

San Francisco, CA, based Investment company Farallon Capital Management Llc (Current Portfolio) buys The Medicines Co, Salesforce.com Inc, Thermo Fisher Scientific Inc, IAC/InterActiveCorp, AbbVie Inc, sells Celgene Corp, Altaba Inc, Citrix Systems Inc, Alibaba Group Holding, Buckeye Partners LP during the 3-months ended 2019Q4, according to the most recent filings of the investment company, Farallon Capital Management Llc. As of 2019Q4, Farallon Capital Management Llc owns 102 stocks with a total value of $12.2 billion. These are the details of the buys and sells.

For the details of FARALLON CAPITAL MANAGEMENT LLC's stock buys and sells, go to https://www.gurufocus.com/guru/farallon+capital+management+llc/current-portfolio/portfolio

These are the top 5 holdings of FARALLON CAPITAL MANAGEMENT LLC
  1. SPDR S&P 500 (SPY) - 4,385,000 shares, 11.58% of the total portfolio.
  2. IAC/InterActiveCorp (IAC) - 2,066,500 shares, 4.22% of the total portfolio. Shares added by 41.78%
  3. Fidelity National Information Services Inc (FIS) - 3,485,757 shares, 3.98% of the total portfolio. Shares added by 14.08%
  4. Westinghouse Air Brake Technologies Corp (WAB) - 5,069,187 shares, 3.24% of the total portfolio. Shares reduced by 19.16%
  5. Anthem Inc (ANTM) - 1,250,000 shares, 3.10% of the total portfolio. Shares added by 17.60%
New Purchase: The Medicines Co (MDCO)

Farallon Capital Management Llc initiated holding in The Medicines Co. The purchase prices were between $49.68 and $84.94, with an estimated average price of $67.5. The stock is now traded at around $84.90. The impact to a portfolio due to this purchase was 2.31%. The holding were 3,315,000 shares as of .

New Purchase: Salesforce.com Inc (CRM)

Farallon Capital Management Llc initiated holding in Salesforce.com Inc. The purchase prices were between $142.33 and $164.98, with an estimated average price of $157.07. The stock is now traded at around $186.25. The impact to a portfolio due to this purchase was 2.3%. The holding were 1,724,880 shares as of .

New Purchase: Thermo Fisher Scientific Inc (TMO)

Farallon Capital Management Llc initiated holding in Thermo Fisher Scientific Inc. The purchase prices were between $271.93 and $328.04, with an estimated average price of $304.01. The stock is now traded at around $323.03. The impact to a portfolio due to this purchase was 2.27%. The holding were 853,160 shares as of .

New Purchase: Anixter International Inc (AXE)

Farallon Capital Management Llc initiated holding in Anixter International Inc. The purchase prices were between $66.46 and $92.97, with an estimated average price of $81.43. The stock is now traded at around $98.04. The impact to a portfolio due to this purchase was 0.69%. The holding were 917,893 shares as of .

New Purchase: Qiagen NV (QGEN)

Farallon Capital Management Llc initiated holding in Qiagen NV. The purchase prices were between $25.41 and $43.1, with an estimated average price of $35.32. The stock is now traded at around $36.78. The impact to a portfolio due to this purchase was 0.6%. The holding were 2,154,000 shares as of .

New Purchase: Audentes Therapeutics Inc (BOLD)

Farallon Capital Management Llc initiated holding in Audentes Therapeutics Inc. The purchase prices were between $25.55 and $59.84, with an estimated average price of $37.91. The stock is now traded at around $59.97. The impact to a portfolio due to this purchase was 0.58%. The holding were 1,190,000 shares as of .

Added: IAC/InterActiveCorp (IAC)

Farallon Capital Management Llc added to a holding in IAC/InterActiveCorp by 41.78%. The purchase prices were between $212.59 and $252.5, with an estimated average price of $225.94. The stock is now traded at around $221.57. The impact to a portfolio due to this purchase was 1.24%. The holding were 2,066,500 shares as of .

Added: AbbVie Inc (ABBV)

Farallon Capital Management Llc added to a holding in AbbVie Inc by 150.00%. The purchase prices were between $72.13 and $90.25, with an estimated average price of $83.36. The stock is now traded at around $93.21. The impact to a portfolio due to this purchase was 1.09%. The holding were 2,500,000 shares as of .

Added: Microsoft Corp (MSFT)

Farallon Capital Management Llc added to a holding in Microsoft Corp by 54.55%. The purchase prices were between $134.65 and $158.96, with an estimated average price of $147.3. The stock is now traded at around $171.00. The impact to a portfolio due to this purchase was 1%. The holding were 2,185,790 shares as of .

Added: Palo Alto Networks Inc (PANW)

Farallon Capital Management Llc added to a holding in Palo Alto Networks Inc by 81.71%. The purchase prices were between $205.41 and $250.28, with an estimated average price of $227.25. The stock is now traded at around $237.13. The impact to a portfolio due to this purchase was 0.94%. The holding were 1,108,416 shares as of .

Added: Exelixis Inc (EXEL)

Farallon Capital Management Llc added to a holding in Exelixis Inc by 328.57%. The purchase prices were between $15.15 and $18.89, with an estimated average price of $16.96. The stock is now traded at around $20.21. The impact to a portfolio due to this purchase was 0.83%. The holding were 7,500,000 shares as of .

Added: Cigna Corp (CI)

Farallon Capital Management Llc added to a holding in Cigna Corp by 41.14%. The purchase prices were between $147.19 and $206.47, with an estimated average price of $184.43. The stock is now traded at around $200.54. The impact to a portfolio due to this purchase was 0.73%. The holding were 1,500,000 shares as of .

Sold Out: Celgene Corp (CELG)

Farallon Capital Management Llc sold out a holding in Celgene Corp. The sale prices were between $97.62 and $110.41, with an estimated average price of $105.2.

Sold Out: Altaba Inc (AABA)

Farallon Capital Management Llc sold out a holding in Altaba Inc. The sale prices were between $19.63 and $19.63, with an estimated average price of $19.63.

Sold Out: Citrix Systems Inc (CTXS)

Farallon Capital Management Llc sold out a holding in Citrix Systems Inc. The sale prices were between $95.18 and $114.04, with an estimated average price of $107.93.

Sold Out: Buckeye Partners LP (BPL)

Farallon Capital Management Llc sold out a holding in Buckeye Partners LP. The sale prices were between $41.25 and $41.46, with an estimated average price of $41.4.

Sold Out: AstraZeneca PLC (AZN)

Farallon Capital Management Llc sold out a holding in AstraZeneca PLC. The sale prices were between $42.46 and $50.46, with an estimated average price of $47.19.

Sold Out: Sea Ltd (SE)

Farallon Capital Management Llc sold out a holding in Sea Ltd. The sale prices were between $26.7 and $40.22, with an estimated average price of $33.85.



Here is the complete portfolio of FARALLON CAPITAL MANAGEMENT LLC. Also check out:

1. FARALLON CAPITAL MANAGEMENT LLC's Undervalued Stocks
2. FARALLON CAPITAL MANAGEMENT LLC's Top Growth Companies, and
3. FARALLON CAPITAL MANAGEMENT LLC's High Yield stocks
4. Stocks that FARALLON CAPITAL MANAGEMENT LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)